chartexchange

Azitra Q3 Loss Widens to $2.95 Million as Going Concern Doubt Remains

Securities.io | Nov 12, 2026 6:53 PM EST

Azitra’s third-quarter results release, issued November 12, 2026, showed a net loss of $2.95 million, compared with $2.76 million a year earlier, as the clinical-stage dermatology company advanced two programs toward data readouts. Cash and cash equivalents totaled $3.75 million at September 30, 2026. Its quarterly filing disclosed substantial doubt about Azitra’s ability to continue as a going concern for twelve months from the financial statements’ issuance date. That warning shifts attention…

Read original article